TechFDA Approves New Alzheimer's Drug, Bringing Hope of Slowing Disease for US Patients The US Food and Drug Administration (FDA) gave a green light to Eli Lilly's Kisunla, a new Alzheimer's drug that slightly delays the disease's progression.by Inno Flores
HealthIndia Panel Backs Eli Lilly's Mounjaro, Weight Loss Drug Set to Enter Indian Marketby John Lopez
HealthDiabetes Relief: Major Manufacturers Cap Insulin Prices at $35, Answering Calls for Affordability in the USby Quincy Jon
HealthEli Lilly's Weight-Loss Drug Users Regain Over 20 Pounds After Discontinuation, Study Revealsby Quincy Jon
Healthy Living/WellnessCholesterol Drug Evacetrapib Does Not Reduce Cardiovascular Eventsby Katrina Pascual
Healthy Living/WellnessEli Lilly's Jardiance Diabetes Treatment Steals Market Share From Rival Drugsby Katrina Pascual
Healthy Living/WellnessFDA Approves Eli Lilly's Drug Basaglar For Diabetes Treatmentby Katrina Pascual
Healthy Living/WellnessEli Lilly, Incyte Announce Baricitinib Superior To Methotrexate In Alleviating Rheumatoid Arthritisby Dianne Depra
Pete Hegseth Reportedly Shared Details of Yemen Attacks in Another Signal Chat That Has His Wife in It